Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 558-569, May 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuhira, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuhira, K.

Damage to the Thymus and Other Lymphoid Tissues from 3-Methylcholanthrene, and Subsequent Thymoma Production, in Mice*

Kimio Yasuhira{dagger}

( Dept. of Medical Microbiology and Dept. of Pediatrics, Stanford University, Palo Alto, Calif.)

Serious damage in lymphoid tissues was seen on post-mortem examination of CF1 Swiss and C57BL mice subjected to intraperitoneal injection of 3-methylcholanthrene (MC) between 12 hours and 9 days after birth. In life such mice exhibited an acute or chronic wasting syndrome clinically and histologically similar to runting syndromes occurring after immunological procedures, but presumably different in origin.

Thymomas were produced in many of the CF1 Swiss mice surviving more than 2 months after MC injection, but not in any C57BL mice. Lung adenomas and some other tumors were produced in other CF1 mice between 5 and 8 months after treatment.

* This study was supported in part by Training Grant ZE-82, U. S. Public Health Service, awarded to the Dept. of Medical Microbiology, Stanford University; and in part by an Institutional Grant to Stanford University from the American Cancer Society.

{dagger} Present address: Tuberculosis Research Institute, Kyoto University, Kyoto, Japan.

Received 7/17/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.